Scinovex
article Open AccessTop 10% cited

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

British Journal of Cancer · 1995 · Vol. 71(3) · pp. 587–591
Seppo PyrhönenTapio KuitunenPaul NyandotoMauri Kouri
Gastric Cancer Management and OutcomesColorectal Cancer Treatments and StudiesGastrointestinal Tumor Research and TreatmentMedicineNauseaVomitingInternal medicineGastroenterologyFluorouracilMethotrexateChemotherapyCancerSurgery

MeSH terms

AdultAgedAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyDrug Administration ScheduleFemaleFluorouracilHumansMaleMethotrexateMiddle AgedNeoplasm MetastasisPalliative CareStomach NeoplasmsVitamin A
Citations
794
FWCI
5.92
field-weighted impact
References
19
Percentile
96%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer · Scinovex